Lumida
/SEPN
⌘K
Septerna Inc

Septerna Inc

SEPN
$38.51USD+2.01%+0.76 today

MARKET CAP

1.8B

P/E (TTM)

FWD P/E

DAY RANGE

$38 – $40

52W RANGE

$14
$51

AI Summary

Stalk
StalkMedium

SEPN remains in a Stage 2 uptrend but is consolidating between its 9/20 EMAs and the 50-day SMA. Short-term momentum is neutral, and price is holding above the rising 50-day SMA. A disciplined pullback entry into support is preferred, awaiting clear re-acceleration above the 20-day EMA before committing.

  • Unanimous buy consensus across 10 analysts; $45.00 avg. target (+27.9%)
  • SEP-479 preclinical results show promising PTH1R agonist progress
  • Q2 EPS forecast at -$0.426; Q1 EPS exceeded estimates at -$0.19
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2024FY 2025TREND
Sales, Adj.$1.1M$46.0M
YoY %+4174.5%
P / Sales210.7x26.9x
EV / Sales23.1x28.9x
Gross Profit, Adj.$1.1M$46.0M
YoY %+4174.5%
Margin %100.0%100.0%
EV / Gross Profit23.1x28.9x
EBITDA, Adj.$-79.4M$-79.2M
YoY %+0.3%
Margin %-7388.1%-172.3%
EV / EBITDA-0.3x-16.8x
EBIT$-80.8M$-80.8M
YoY %+0.0%
Margin %-7518.4%-175.8%
EV / EBIT-0.3x-16.4x
Net Income$-71.8M$-48.9M
YoY %+31.9%
Net Margin-6678.9%-106.4%
EPS (GAAP)-$7.26-$1.10
YoY %+84.8%